Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Gamer

Could coronavirus turn us all into online gamers?

As businesses gauge the potential impact of coronavirus (COVID-19), with a sense of fear and pessimism causing a dampening of economic activity and suspension of the stock market, the healthcare...

Page & Page Health

- PMLiVE

US Department of Health and Human Services calls for coronavirus product proposals

Move will fast-track the development of potential treatments

- PMLiVE

UK government considers move into ‘delay’ phase of coronavirus response plan

Proposed emergency measures could include 'social distancing'

- PMLiVE

Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout

Pivotal mid-stage trial results due later this month

- PMLiVE

FDA approves Recordati’s Cushing disease drug Isturisa

Important new treatment option for patients with rare disorder

- PMLiVE

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

Grant will help accelerate medicine registration in low/middle-income countries

- PMLiVE

FDA approves Allergan’s biodegradable glaucoma implant drug

Reduces intraocular pressure in glaucoma or ocular hypertension

- PMLiVE

Zydus Cadila scores first ever NASH approval, in India

Drug has already been approved for diabetes related conditions

AstraZeneca AZ

AstraZeneca’s Imfinzi fails first-line bladder cancer test

Unable to improve overall survival in advanced metastatic bladder cancer

- PMLiVE

Trevena gets second go at FDA approval for pain drug

FDA sets review completion date of 7 August 2020

13th Edition – Spring MEDAFFAIRS Leaders Forum

OPEN VIE (Amanda Pulfer, Strategic Director and Sergio Diaz, Patient Centred Outcomes Consultant) were delighted to speak at the Medical Affairs Leaders Forum yesterday.

OPEN Health

- PMLiVE

Havas Life Medicom strengthens team with a host of hires

Agency grows its offering with 16 new hires

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links